Guy Breitenbucher brings more than 25 years of experience in the pharmaceutical industry to this team. He received his PhD in chemistry from the University of California, Riverside and conducted postdoctoral training at the University of California, Berkeley. Dr. Breitenbucher has advanced several programs into clinical development across a broad spectrum of indications related to the central nervous system, while leading medicinal chemistry teams and departments at both large and small biopharmaceutical companies.
Associated Grants
-
Testing Small Molecules that Activate Removal of Cellular Debris for the Treatment of Parkinson’s Disease
2022